Subscribe To
Viking therapeutics joins weight loss drug bandwagon as trial data impresses
Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a tre...
October 18, 2023, 7:06 am
Passion fruit extract market to reach us$ 1,420.3 million by 2033, fueled by insomnia treatment | future market insights, inc.
Passion fruit extract, a potent antioxidant, gains popularity in diverse applications, including insomnia trea...
October 18, 2023, 12:30 am
Dow jones newswires: takeda trial for crohn’s perianal fistulas treatment misses primary endpoint
Takeda said Tuesday its trial of darvadstrocel in the treatment of complex Crohn’s Perianal Fistulas ...
October 18, 2023, 12:12 am
: ardelyx wins long battle for fda approval of kidney-disease treatment
Drug previously rejected by regulators gets green light and is set to launch later this year Read Full Story The post : Ardelyx wins long battle for F...
October 17, 2023, 11:24 pm
J&j's medical device sales feel the side effects of weight-loss drugs
Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%. The pha...
October 17, 2023, 11:05 pm
Cyclarity therapeutics announces clinical advisory board
NOVATO, Calif, Oct. 17, 2023 (GLOBE NEWSWIRE) — Cyclarity Therapeutics, Inc. (https://cyclaritytx.com), today announced its newly formed Clinical Ad...
October 17, 2023, 10:04 pm
Ncr voyix debuts on new york stock exchange
NCR Voyix, a provider of digital commerce solutions, has made its debut on the New York Stock Exchange following the spinoff of its ...
October 17, 2023, 9:56 pm
Brink’s schedules third-quarter 2023 earnings release and conference call for november 7, 2023
RICHMOND, Va., Oct. 17, 2023 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digita...
October 17, 2023, 9:05 pm
Takeda trial for crohn's perianal fistulas treatment misses primary endpoint
Takeda 4502, -0.33% said Tuesday its trial of darvadstrocel in the treatment of complex Crohn's Periana...
October 17, 2023, 8:12 pm
Ardelyx wins long battle for fda approval of kidney-disease treatment
Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment des...
October 17, 2023, 7:24 pm
Brink's schedules third-quarter 2023 earnings release and conference call for november 7, 2023
RICHMOND, Va., Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE:BCO), a leading global provider of cash and valuables management, digital r...
October 17, 2023, 5:05 pm
Gynesonics’ incision-free sonata procedure for the treatment of uterine fibroids reaches patient milestones in the u.s. and globally
REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally inv...
October 17, 2023, 4:00 pm
European equity close: second day of largely-flat trading
We've painted a couple days of dojis on the STOXX 600 chart.Closing changes:Stoxx 600 -0.1%German DAX flatUK FTSE 100 +0.6%French CAC flatItaly MIB -0...
October 17, 2023, 3:43 pm
Abbvie: q2 success sets the stage for consistent growth
AbbVie is a leading pharmaceutical company with a strong history and a diverse portfolio of products. The company's flagship product, Humira, has gene...
October 17, 2023, 1:58 pm
Editas (edit) gets fda's rmat tag for gene therapy to treat scd
The FDA bestows Regenerative Medicine Advanced Therapy designation to Editas' (EDIT) gene editing therapy, EDIT-301, for the tre...
October 17, 2023, 1:31 pm
Astrazeneca's (azn) tagrisso combo gets fda's priority review
The FDA accepts and grants priority review to AstraZeneca's (AZN) sNDA, seeking approval of Tagrisso combined with chemotherapy as a first-line tre
October 17, 2023, 12:46 pm
Ugi vs. ato: which stock is the better value option?
Investors interested in stocks from the Utility - Gas Distribution sector have probably already heard of UGI (UGI) and ...
October 17, 2023, 12:46 pm
Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)
Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...
October 17, 2023, 12:05 pm
Ocean biomedical (nasdaq: ocea) announces enrollment of patients for phase 1b study for chronic hepatitis b treatment in 50-50 joint venture with virion therapeutics
Providence, Rhode Island, Oct. 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the deve...
October 17, 2023, 12:01 pm
Evelo biosciences shares tank 46% after trial failure
Evelo Biosciences' shares have tumbled 46% in premarket trading after the biotech firm revealed disappointing results in a phase II psoriasis trial fo...
October 17, 2023, 9:00 am